During the past decade, University of Arizona Department of Psychiatry conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arizona Department of Psychiatry" #1 sponsor was "University of Arizona" with 8 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Forest Laboratories" with 1 trials sponsored and "William D. Killgore" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arizona Department of Psychiatry" #1 collaborator was "United States Department of Defense" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator and "U.S. Army Medical Research Acquisition Activity" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University of Arizona Department of Psychiatry" are "Major Depressive Disorder" (4 trials), "Bipolar Disorder With Psychotic Features" (2 trials), "Depressive Disorder, Major" (2 trials), "Major Depression With Psychotic Features" (2 trials) and "Schizoaffective Disorder" (2 trials). Many other conditions were trialed in "University of Arizona Department of Psychiatry" in a lesser frequency.

Most popular intervention types in "University of Arizona Department of Psychiatry" are "Drug" (8 trials), "Behavioral" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Rapastinel" (2 trials), "ATMX" (1 trials), "Active cTBS" (1 trials) and "DVS SR" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Arizona Department of Psychiatry" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Arizona Department of Psychiatry". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in University of Arizona Department of Psychiatry, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Arizona Department of Psychiatry, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".